Graham Capital Management’s Elanco Animal Health ELAN Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2025
Q1
– Sell
-150,897
Closed -$1.83M – 1347
2024
Q4
$1.83M Buy
150,897
+58,148
+63% +$761K 0.03% 318
2024
Q3
$1.36M Buy
92,749
+64,816
+232% +$903K 0.02% 383
2024
Q2
$403K Sell
27,933
-55,308
-66% -$884K 0.01% 652
2024
Q1
$1.36M Buy
+83,241
New +$1.3M 0.03% 337
2023
Q1
– Sell
-23,058
Closed -$282K – 1126
2022
Q4
$282K Sell
23,058
-204,949
-90% -$2.55M 0.01% 915
2022
Q3
$2.83M Buy
228,007
+207,597
+1,017% +$3.63M 0.11% 138
2022
Q2
$400K Buy
+20,410
New +$483K 0.02% 739
2022
Q1
– Sell
-13,702
Closed -$388K – 922
2021
Q4
$388K Buy
+13,702
New +$426K 0.02% 235

Other funds holding ELAN

Graham Capital Management's ELAN Position: Q1 2025 in Review

Graham Capital Management sold out of Elanco Animal Health (ELAN) in Q1 2025, closing a stake of 150,897 shares — an estimated $1.83M sold.

Graham Capital Management first reported a position in ELAN in Q4 2021 and held it in 8 quarters. The position peaked at $2.83M in Q3 2022. 365 funds tracked by Wall St. Rank hold ELAN as of Q1 2025.

  • Graham Capital Management reported no remaining Elanco Animal Health position as of Q1 2025 after selling out during the quarter.
  • Graham Capital Management sold 150,897 Elanco Animal Health shares in Q1 2025, an estimated $1.83M.
  • Graham Capital Management first reported a position in Elanco Animal Health in Q4 2021 and held it in 8 quarters.
  • Graham Capital Management's Elanco Animal Health position peaked at $2.83M in Q3 2022.
  • 365 funds tracked by Wall St. Rank held Elanco Animal Health as of Q1 2025.

Based on Graham Capital Management's 13F filing for Q1 2025, filed 15 May 2025.